STUDY TO EVALUATE 13 VALENT PNEUMOCOCCAL CONJUGATE VACCINE (13VPNC) VACCINE FOLLOWED BY 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23VPS) VACCINE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: